We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 05 Feb 2020
Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre. More...
As the MENA region’s largest medical laboratory exhibition and congress, MEDLAB Middle East plays a crucial role in developing the value of laboratory medicine in transforming tomorrow’s diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase new innovations, collaborate and network. MEDLAB Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 4th year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from over 135+ countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.

With laboratory services in the MEA region expected to grow at a compound annual growth rate (CAGR) of 3.8% until 2023, the 2020 edition of the show witnessed an increase in both the value of business and the number of attendees in comparison to last year. The four-day show organized by Informa Markets hosted the inaugural Transformation Hub, a dedicated zone showcasing advanced clinical laboratory products by the SMEs and new-to-market pioneers that are transforming diagnostics and advancing healthcare. The zone also featured the Transformation Talks sessions where manufacturers introduced new launches and in-demand solutions. Some of the key areas that were highlighted at the Transformation Hub included automation, healthcare information technology (HIT) and laboratory measurement testing and technology.

In addition to the Transformation Hub, MEDLAB Middle East also hosted a series of free-to-attend workshops, hosted by the National Reference Laboratory (NRL) and Bio-Rad, where a hands-on approach to learning and knowledge-sharing on new product offerings, technology and best practice took place. Workshops included Transfusion and blood typing challenges; Laboratory quality management system, the best of CLSI; and Laboratory accreditation, CAP updates.

MEDLAB Middle East also offered an educational agenda for clinical laboratory specialists to advance their skill sets, inspire and to provide advanced medical laboratory techniques for better health. More than 4,500 conference delegates had the opportunity to hear from 120 speakers from around the world, across 12 Continuing Medical Education (CME) accredited conferences.

The 2020 edition of the show saw the introduction of four new conference tracks, including Blood Transfusion Medicine, Laboratory Innovation, Digital Pathology and the Roundtable Discussions, which featured focused scientific group discussions on selected administration and technical topics in the medical laboratory.

“MEDLAB Middle East provides the ideal platform to showcase groundbreaking products to the medical laboratory industry here in the Middle East, while also sharing research and educational initiatives to visitors and delegates from around the word,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.